The NLR family pyrin domain-containing 3 (NLRP3) inflammasome plays an important role in liver fibrosis (LF) development. However, the mechanisms involved in NLRP3-induced fibrosis are unclear. Our aim was to test the hypothesis that the NLRP3 inflammasome in hepatic stellate cells ( 
NLR Family Pyrin Domain-Containing 3 Inflammasome Activation in Hepatic Stellate Cells Induces Liver Fibrosis in Mice
Maria Eugenia Inzaugarat, 1 investigated member of the NLR inflammasome family is NLR family pyrin domain-containing 3 (NLRP3), activation of which can occur in response to a wide range of stimuli, including pathogens and sterile insults, (3) by the generation of mitochondrial-derived reactive oxygen species (ROS) or cathepsin B activation and deubiquitination, among other mechanisms. (4, 5) Upon stimulation, components of the NLRP3 inflammasome are recruited and assembled, leading to cleavage of pro-Casp1 into its active form, which, in turn, cleaves prointerleukin (IL)-1β and pro-IL-18 into their mature forms.
(1) Noncanonical Casp-11-dependent NLRP3 activation has been shown to involve gasdermin cleavage and release of high-mobility group box 1 (HMGB1) and IL-1α. (6) Inflammasome activation and IL-1β production have been associated with several chronic liver diseases (CLDs), including fibrosis development. (7) One of the central features of fibrotic changes within the liver is the augmented production of extracellular matrix (ECM) proteins, including collagen (Col) fibers. Hepatic stellate cells (HSCs) represent the major liver mesenchymal cell type playing a key role in fibrosis, attributed to their activation and subsequent transdifferentiation into myofibroblasts leading to ECM deposition and scar tissue formation upon sustained injury. (8) (9) (10) Recent studies from our lab using constitutively activated Nlrp3 mutant mice demonstrated that NLRP3 activation is required for hepatic inflammation and fibrosis, potentially through tumor necrosis factor (TNF) signaling, as well as for inducing the programmed inflammatory cell death known as pyroptosis. (11) (12) (13) However, it remains unclear whether HSC activation is the result of intracellular NLRP3 activation or a consequence of inflammasome activation in the surrounding milieu. Thus, we aimed to test our working hypothesis that the NLRP3 inflammasome activated in HSC directly contributes to liver fibrosis (LF) development.
Materials and Methods

aNIMal MoDelS
The following mouse strains were used in this study: C57BL/6 wild types (WTs) and Nlrp3 -/-.
Nlrp3
L351PneoR mice were generated as described, with a leucine 351 to proline (L351P) substitution and the presence of an intronic floxed neomycin resistance cassette, in which expression of the mutation does not occur unless the Nlrp3
L351PneoR mutants are first bred with mice expressing Cre recombinase. (14) Nlrp3 L351PneoR mice were bred to B6.Cg-Tg (Cre/Esr1)5Amc/J (CreT) mice generating conditional knock-in mice in which the mutation is inducible with tamoxifen or to transgenic mice expressing lecithin retinol acyltransferase (Lrat)-driven Cre (Lrat Cre) coexpressing tdTomato + , in which hepatic expression of mutant Nlrp3 L351P is restricted to HSCs. Eight male Nlrp3 L351P/+ Lrat Cre and 8 male littermate mice were maintained on a standard rodent chow for 24 weeks. At this time point, mice were sacrificed and liver tissue and serum were harvested.
lIpopolySaCCHaRIDe CHalleNge
Ten male Lrat-Cre Nlrp3 L351P and 10 littermate control mice at 8 weeks of age were included. Half of the mice in each group were given a single intraperitoneal injection of lipopolysaccharides (LPSs) from Escherichia coli 0127:B8 (Sigma-Aldrich, St. Louis, MO) whereas the other half were injected with saline solution. LPS was injected at a concentration of 2.5 mg/kg, and mice were sacrificed and livers were collected 6 hours postinjection.
All procedures were approved by German local governmental authorities (Landesamt für Natur, Umwelt und Verbraucherschutz Nordrhein-Westfalen, LANUV NRW) and the Institutional Animal Care and Use Committee at the University of California, San Diego (San Diego, CA). All efforts were made to minimize pain and distress during animal husbandry and experimental assessments.
HSC ISolatIoN aND StIMUlatIoN
For isolation of HSCs, 24-week-old female or male mice were used. Briefly, mice were anesthetized by ketamine/xylazine injection and perfused in situ through the inferior vena cava with sequential Pronase E (0.4 mg/mL) and Collagenase D (0.8 mg/mL) solutions. Liver was removed and digested in vitro with Collagenase D (0.5 mg/mL), Pronase E (0.5 mg/mL), and DNAse I (0.02 mg/mL). After 20 minutes, tissue was filtered through a 70-µm mesh. Cells were separated using a Nycodenz gradient centrifugation. HSCs were sorted by gating for tomato-positive signaling or seeded into plastic tissue culture flasks in Dulbecco's modified Eagle's medium containing fetal serum and incubated at 37°C with CO 2 overnight. In order to deplete any macrophage contamination, the HSC layer was treated with clodronate liposomes (5 mg/mL) for 4 hours at 37°C as described. (15) The next morning, the culture medium was changed and inflammasome activation in HSC was induced with LPS (1 µg/mL) for 3 hours and either adenosine triphosphate (ATP; 5 mM) for 1 hour or with 4-hydroxytamoxifen (4-OHT), the active metabolite of tamoxifen, for 24 hours. In addition, HSCs were coincubated with CA-074-Me (20 µM; Sigma-Aldrich) to inhibit cathepsin B activity. In an independent experiment, HSCs were stimulated with transforming growth factor beta (TGF-β; 100 ng/mL) for 4 hours.
HIStology, IMMUNoStaININg, aND SIRIUS ReD StaININg
Liver tissues were fixed, embedded in paraffin, and processed on slides for hematoxylin-eosin (H&E) or Sirius Red staining. Histopathological staging of LF was performed by an experienced pathologist. Primary monoclonal antibodies used to perform immunostaining were: anti-F4/80 (a murine pan-macrophage marker; AbDSerotec, Hercules, CA), antimyeloperoxidase (MPO; Thermo Fisher Scientific, Waltham, MA), alpha smooth muscle actin (αSMA; Abcam, Cambridge, UK), anti-collagen alpha 1a (Col1a1; BioTrend, Germany), anti-IL-1β (Abcam), anti-NLRP3 (AdipoGen, San Diego, CA), and antidesmin (Thermo Fisher Scientific); the negative controls in all procedures omitted primary antibody. Cells were fixed with prechilled methanol and blocked with 5% bovine serum albumin (BSA) in phosphate-buffered saline with Tween-20 while the slides were deparaffinized and hydrated in ethanol and the antigens were retrieved in citrate buffer (pH 6.0) for 20 minutes at 95°C or treated with 2% BSA 1× Triton in tris-buffered saline with Tween-20 for 30 minutes at room temperature. Following overnight incubation with primary antibodies, horseradish peroxidase (HRP) or Alexa-Fluor 488-or Alexa-Fluor 546-conjugated second antibody (Thermo Fisher Scientific) was applied. For color reaction of HRP, streptavidin-peroxidase complex 3,3-diaminobenzidine tetrahydroxychloride was used as chromogen and slides were counterstained with hematoxylin. Mounting solution containing 4',6-diamidino-2-phenylindole (DAPI; Vector Laboratories, Burlingame, CA) was used to counterstain the nuclei. 
Real-tIMe pCR
Total RNA was isolated using PeqGold TriFast following the manufacturer's instruction (PEQLAB Biotechnologie GmbH, Erlangen, Germany). The reverse transcript (complementary DNA; cDNA) was synthesized from total RNA using the iScript cDNA Synthesis kit (Bio-Rad, Hercules, CA). Real-time PCR quantification was performed using Fast Sybr-Green and QuantStudio 6 (Applied Biosystems, Beverly, MA). Sequences of the primers used for quantitative PCR are given in Supporting  Table S1 .
FloW CytoMetRy aNalySIS
After stimulation, HSCs were harvested, permeabilized, and incubated with vimentin (Vim) phycoerythrin (PE)-conjugated antibody (R&D Systems, Minneapolis, MN). To assess Casp-1 activity, FLICA FAM-YVAD-FMK (FAM-FLICA Caspase-1 Assay Kit; ImmunoChemistry Technologie) was used, following the manufacturer's instructions. In order to measure ROS production, cells were incubated with 2′,7′-dichlorofluorescein (DCF; 2′,7′-dichlorodihydrofluorescein diacetate; Sigma-Aldrich) for 30 minutes at 37°C and analyzed by flow cytometry at 500 nm (BD Canto II). Macrophage contamination was evaluated by staining HSCs with F4/80 PE (eBioscience, Hatfield, UK) for 30 minutes at 4°C.
IMMUNoBlottINg aNalySIS aND eNZyMe-lINKeD IMMUNoSoRBeNt aSSay
Immunoblotting analysis was performed as previously described. Anti-LRAT (Donated by Dr. Palczewski, University of Washington, Seattle, WA), anti-NLRP3 (Adipogen), anti-IL-1β (Abcam), antiCasp-1 (Santa Cruz Biotechnology, Dallas, TX), anti-αSMA (Abcam), and anti-CTGF (connective tissue growth factor; Abcam) antibodies were used in combination with appropriate peroxidase-conjugated secondary antibodies. Protein load was verified with glyceraldehyde 3-phosphate dehydrogenase (GAPDH) antibody (Abcam). Bands were visualized with the enhanced chemiluminescence substrate (Bio-Rad) and digitized using a charge-coupled device camera (ImageQuant LAS4000; GE Healthcare, Chicago, IL). Quantification of IL-1β levels in supernatant was performed according to the manufacturer's instruction (PeproTech, Hamburg, Germany). Hydroxyproline levels were measured using a standard chemical assay.
StatIStICal aNalySIS
Analyses were performed with GraphPad software (version 7.0; GraphPad Software Inc., La Jolla, CA). Significance level was set at α = 5% for all comparisons. A nonparametric Mann-Whitney U test was used for two-group comparison. For experiments involving three or more groups, data were evaluated using the Kruskal-Wallis test and Dunn's multiple comparison test. Unless otherwise stated, data are expressed as mean ± SEM.
Results
lpS tRIggeRS CaNoNICal NlRp3 INFlaMMaSoMe aCtIVatIoN IN ISolateD HSCS
We first assessed the purity of isolated HSCs and macrophage contamination. Fluorescence-activated cell sorting (FACS) analysis showed that the mean percentage of F4/80 + cells was 1.45%, which, along with the evaluation of blue autofluorescence of retinoid droplets containing vitamin A, indicates that isolated HSCs exceeded 98% purity (Supporting Fig. S1A-D) .
Next, to confirm that HSCs possess a completely functional inflammasome, we first stimulated cells with LPS as a first signal for NLRP3 activation, followed by ATP as a second signal. Stimulation of WT cells with LPS induced up-regulation of Nlrp3 and proIl1b mRNA levels that were further increased when cells were subsequently incubated with ATP (Fig. 1A) , an effect that was not present in Nlrp3 -/-HSCs.
FIg. 1.
Induction of canonical NLRP3 inflammasome activation accompanied by ROS production and cathepsin B in HSCs by LPS/ATP. Cultured HSCs from WT mice, but not from Nlrp3 -/-, display augmented protein and mRNA expression levels for Nlrp3 and pro-Il1b as well as mature IL-1β (supernatant) after LPS and/or LPS/ATP stimulation (A,B). Flow cytometry analysis showed that WT HSCs increase Casp-1 activity after LPS/ATP stimulation, which was not observed in Nlrp3 -/-HSCs (C). mRNA levels of Casp11, Il1a, and Hmgb1, effectors of noncanonical activation of NLRP3, are not affected by LPS or LPS/ATP stimulation (D). LPS triggers ROS production in WT HSCs, evidenced by increased DCF fluorescence, which was further enhanced after subsequent ATP stimulation, an effect not present in Nlrp3 -/-HSCs (E). Increased cathepsin B was detected in WT HSCs after LPS/ATP stimulation. Interestingly, Nlrp3 -/-HSCs showed reduced cathepsin B levels compared to WT HSCs (six replicates were included for all measured values; *P < 0.05; **P < 0.01).
Moreover, increased production of mature IL-1β was observed in the supernatant of WT, but not Nlrp3 -/-, HSCs after incubation with LPS and ATP (Fig. 1B) . Immunostaining confirmed that WT cells were able to increase IL-1β expression when stimulated with LPS followed by ATP, whereas Nlrp3 -/-HSC failed to respond (Fig. 1C) . In order to confirm that the NLRP3 inflammasome was active, Casp-1 activity was measured by flow cytometry and quantified by normalizing mean fluorescence intensity (MFI) of stimulated cells to basal conditions. Increased Casp-1 activity was observed in WT, but not Nlrp3 -/-, cells after LPS and ATP stimulation (Fig. 1D) . Casp11, Il1a, and Hmgb1 mRNA levels were unchanged after LPS or LPS/ATP stimulation, ruling out the presence of noncanonical NLRP3 inflammasome activation (Fig. 1E ). To rule out that the changes observed were attributed to an indirect effect by macrophage contamination and their interaction with HSCs, HSCs were treated with clodronate liposomes, which did not prevent up-regulation of Nlrp3 and Il1b mRNA or protein levels or the increase of Casp-1 activity after LPS or LPS and ATP stimulation (Supporting Fig. S2A-D) .
Next, we assessed which mechanism may be involved in activating the inflammasome in HSCs. Using immunofluorescence (IF), we found that cathepsin B was increased only after LPS/ATP treatment in WT HSCs (Fig. 1F) . Likewise, ROS production was augmented after LPS, and further elevated after subsequent ATP incubation, as evidenced by increased DCF intensity measured by FACS (Fig.  1G) . To further dissect its involvement in NLRP3 inflammasome activation, cathepsin B activity was inhibited by incubating HSCs with CA-074-Me (a selective cathepsin B inhibitor), together with LPS and ATP. Immunostaining showed that WT HSCs failed to up-regulate cathepsin B as well as Nlrp3 and IL-1β after LPS and ATP when CA-074-Me was present (Supporting Fig. S3A ). Moreover, supernatant levels of mature IL-1β were not changed in WT HSCs after incubation with LPS followed by ATP in the presence of CA-074-Me when compared to basal conditions (Supporting Fig. S3B ).
No increase in Casp-1 activity was observed in WT after LPS and ATP stimulation in combination with cathepsin B inhibitor (Supporting Fig. S3C ). Taken together, these results suggest that NLRP3 activation in HSCs is mediated, at least in part, by increased ROS production and cathepsin B activation secondary to release of this protease from the lysosome into the cytosol.
Last, we examined the specificity of NLRP3 modulation in HSCs and whether its activation is a common pathway during HSC transdifferentiation into a myofibroblast-like cell. To address this question, we treated HSCs with TGF-β, a known profibrotic factor, and assessed NLRP3 inflammasome activation. Stimulation with TGF-β did not induce up-regulation of Nlrp3 or Il1b mRNA levels or increase the concentration of mature IL-1β in the supernatant, even though WT HSCs showed augmented aSma and Ctgf mRNA levels (Supporting Fig. S4 ).
ISolateD HSCs Up-RegUlate FIBRotIC MaRKeRS aFteR lpSDRIVeN NlRp3 INFlaMMaSoMe aCtIVatIoN
Immunostaining showed that when stimulated with LPS followed by ATP, WT HSCs demonstrated changes in shape, with an increase in Col production and αSMA expression; however, these changes were not observed in Nlrp3 -/-HSCs ( Fig. 2A) . In addition, Vim expression measured by flow cytometry was increased in WT stellate cells after LPS/ATP stimulation whereas Nlrp3 -/-HSCs failed to up-regulate this marker (Fig. 2B) , suggesting that Nlrp3 inflammasome activation leads to up-regulation of fibrosis markers. Along with NLRP3 activation, WT HSCs exhibit augmented mRNA levels of Ctgf, aSma, Tgfb, Vim, and Col1a1 (Fig. 2C) as well as tissue inhibitor of metalloproteinase 1 (Timp1) and matrix metalloproteinase (Mmp)9, but not Mmp2 (Supporting Fig.  S5A) , after LPS or LPS and ATP stimulation; this effect was abrogated in Nlrp3 -/-HSCs. Treatment of HSCs with clodronate liposomes did not prevent up-regulation of these fibrotic markers in WT HSC (Supporting Fig. S2E ).
NlRp3 INFlaMMaSoMe oVeReXpReSSIoN INDUCeS a FIBRotIC pRoFIle IN ISolateD HSCs
To validate that HSC activation can be modulated by NLRP3 inflammasome activation, we isolated cells from Nlrp3 L351P CreT mice-a mouse strain that
FIg. 2.
Effect of NLRP3 inflammasome activation in HSC fibrotic phenotype. After LPS/ATP stimulation, HSC from WT, but not Nlrp3 -/-, mice showed an increase in collagen 1 (Coll1) and αSMA expression along with a change in shape (A). Flow cytometry analysis showed that WT HSCs displayed increased Vim levels after LPS/ATP stimulation, an effect not present in Nlrp3 -/-HSCs (B). mRNA levels of Ctg f, aSma, Tg fb, Vim, and Coll1a1 were found to be increased after LPS and further enhanced after subsequent ATP stimulation (C). HSCs isolated from Nlrp3 L351P/+ CreT showed a pronounced change in shape along with increased collagen 1 and αSMA expression (D), augmented Vim expression measured by FACS (E), and elevated mRNA levels of aSma, Coll1a1, Vim, Ctg f, and Tg fb (F) after NLRP3 inflammasome overactivation was induced by 4-OHT, effects that were intensified after the addition of LPS (six replicates were included for all measured values; *P < 0.05; **P < 0.01). allows for temporal NLRP3 inflammasome activation. After 24-hour 4-OHT induction, NLRP3 inflammasome hyperactivation was confirmed by up-regulated Nlrp3 and pro-Il1b mRNA levels, as well as increased Casp-1 activity, in Nlrp3 mutant HSCs (Supporting Fig. S6 ). We also confirmed previous observations that tamoxifen does not have an effect on inflammasome expression or activation in HSCs that do not express the Nlrp3 mutation secondary to a lack of cre recombinase (Supporting Fig. S7) .
Interestingly, NLRP3 hyperactivation results in the up-regulation of fibrosis markers in stimulated mutant HSCs that further increases after LPS stimulation, as evidenced by elevated mRNA levels of aSma, Col1a1, Vim, Ctgf, and Tgfb (Fig. 2F) as well as Mmp9 and Mmp2 (Supporting Fig. S5B ) compared to the basal condition. Flow cytometry analysis revealed that Vim expression was increased after inducing NLRP3 overexpression in mutant HSCs, an effect that was enhanced when LPS was used to prime the cells (Fig.  2E) . Furthermore, overactivation of Nlrp3 in mutant HSCs resulted in marked morphological changes, along with an observed up-regulation in Col1a1 and αSMA protein expression, which, again, were enhanced in LPS-primed cells (Fig. 2D ).
NlRp3 aCtIVatIoN IN HSCS IN VIVO ReSUltS IN a pHeNotypIC SWItCH to MyoFIBRoBlaStS
As described by Kluwe et al. (16) we observed that LRAT is strongly expressed in HSCs, but absent in other hepatic cell types, such as hepatocytes and Kupffer cells (Supporting Fig S8A) . Furthermore, we confirmed that breeding Nlrp3 L351P/+ mice onto Lrat Cre mice resulted in hyperactivation of NLRP3 within HSCs, as evidenced by colocalization of tdTomato-positive nucleus and augmented expression of NLRP3 in isolated HSCs (Supporting Fig. S8B ). Western blotting of whole-liver lysates showed that inflammasome components, specifically NLRP3, mature IL-1β, and cleaved p-10 Casp-1, were increased in NLRP3 L351P/+ Lrat Cre mice (Fig. 3A,B) , which was further confirmed by elevated mRNA levels of pro-Il1b and pro-Casp1 (Fig. 3C) .
Isolated HSCs from Nlrp3 L351P/+ Lrat Cre mice showed increased protein expression levels of αSMA and desmin, as evidenced by IF staining (Fig. 3E) , which indicates a switch from a quiescent state to a myofibroblast phenotype that was not present in WT HSCs. Moreover, a 3-fold increase in protein expression (Fig. 3F,G) as well as a 2-fold increase in mRNA levels (Fig. 3G) 
peRSISteNt NlRp3 aCtIVatIoN IN HSCs ReSUltS IN lF
In order to assess the effect of persistent NLRP3 activation on the phenotype of HSCs, we used paraffin-embedded liver tissue and stained them with two markers of HSCs. We could detect a significant increase in αSMA (Fig. 4A,B) as well as desmin-positive (Fig. 4A,C 
) cells in Nlrp3
L351P/+ Lrat Cre mice compared to WT littermates. Next, we determined the downstream effect of myofibroblast transdifferentiation, specifically collagen deposition. Sirius Red staining showed an increase in collagen deposition and, moreover, further evaluation by a pathologist confirmed the presence of mild predominantly perisinusoidal fibrosis (Fig. 4A,D) in Nlrp3 L351P/+ Lrat Cre mice. In addition, these changes were accompanied by up-regulation of mRNA levels of Col1a1, Col3a1, and Timp1 (Fig. 4E ) when compared to WT. This increase in Col production was further supported by an increase in hydroxyproline protein concentration (Fig. 4F ) in whole-liver lysate from Nlrp3 L351P/+ Lrat mice compared to littermates.
FIBRotIC CHaNgeS IN lIVeR WeRe INDepeNDeNt oF INFlaMMatIoN oR INJURy
Assessment of basic liver histology did not reveal any signs of hepatocellular injury attributed to inflammation in Nlrp3 L351P/+ Lrat Cre mice (Fig. 5A ). In line with this finding, serum alanine aminotransferase (ALT) levels were unchanged in Nlrp3 L351P/+ Lrat Cre when compared to WT mice (Fig. 5B) . Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining showed no evidence of increased hepatocyte apoptosis in Nlrp3 L351P/+ Lrat Cre mice compared to littermates (Fig. 5A) . Interestingly, fibrotic changes observed within liver were also independent of macrophage infiltration, as evidenced by the lack of alterations in F4/80 expression in liver sections of Nlrp3 L351P/+ Lrat Cre when compared to WT mice (Fig. 5C,D) . Analyses of markers for macrophage activation Ly6c and Tnf also did not differ in Nlrp3
Lrat and WT mice (Fig. 5E) . Expression of MPO, used to assess infiltration of neutrophils, was similar in Nlrp3 L351P/+ Lrat Cre and WT mice (Fig. 5C,D) .
NLRP3 HypeRaCtIVatIoN leaDS to HSC aCtIVatIoN aND FIBRotIC CHaNgeS IN tHe lIVeR aFteR lpS CHalleNge
In order to further investigate the effect of Nlrp3 activation in HSCs on fibrosis development, we injected LPS intraperitoneally and observed the changes in LF markers after 6 hours.
Even though Sirius Red staining showed no significant difference in Col deposition (Fig. 6A,B) , HSC activation markers were increased in Nlrp3 L351P Lrat Cre mice compared to WT after LPS challenge, as evidenced by up-regulation of mRNA levels of Ctgf, Coll1a1, Tgfb, aSma, and Vim (Fig. 6C) . Moreover, a 4-fold increase in αSMA, along with a 1.5-fold increase in CTGF (Fig. 4D) . Further analysis in whole-liver lysates confirmed increased protein expression (E,F) as well as increased mRNA levels (F) of aSma in Nlrp3 L351P/+ Lrat Cre mice compared to control littermates (n = 8 mice per group for all measured values; *P < 0.05; **P < 0.01).
Liver histology revealed a slightly increased inflammation in both Nlrp3 L351P/+ Lrat Cre and WT after 6-hour LPS injection compared to WT, but no difference between the two groups (Supporting Fig.  S9A ). Immunohistochemistry (IHC) of liver sections, as well as mRNA levels, showed that mutant mice did not display an increase in MPO-, F4/80-, or CD68-positive cells compared to littermate animals challenged with LPS (Supporting Fig.  S9A,C) , even though overall levels were increased compared to WT mice. Serum aspartate aminotransferase and lactose dehydrogenase levels were found to be increased compared to littermate controls, but not different between mutant mice and littermate controls post-LPS challenge (Supporting Fig. S9B ). 
Discussion
The findings of the present study highlight NLRP3 inflammasome induction in HSCs as sufficient to trigger their activation and subsequent fibrogenesis independent of inflammation. Our results demonstrate that when NLRP3 activation in HSCs is induced by either inflammasome inducers, or through a point mutation causing a ligand-independent overactivation, HSCs display up-regulation of several fibrotic markers (Tgfb, aSma, Vim, Col1a1, Mmp9, and Timp1) and shift their phenotype to myofibroblasts. Moreover, HSC-specific NLRP3 inflammasome overactivation initiated pathways in vivo related to fibrogenesis that resulted in signs of LF and collagen deposition (Col1a1, Col3a1, and Timp1) without evident changes in hepatic inflammatory infiltrates (F4/80, MPO-positive cells), which can be further exacerbated by an LPS challenge (Fig. 7) . Fibrosis is the result of a sustained scarring response to chronic liver injury, which gradually disrupts liver architecture and causes vascular distortion, eventually leading to cirrhosis. (17) Several sources functioning as important players in LF development have been identified. However, activated HSCs represent the fundamental fibrogenic cell type involved in this process independent of the etiology of liver damage. (9, 18) Upon sustained liver damage, HSCs undergo an activation process that involves increased expression of TIMP-1, as well as ECM proteins such as collagens. (19) Moreover, aberrant activation and proliferation of HSCs together with exacerbated metabolism of ECM proteins are crucial factors in LF initiation and development. (20) Exploring cellular and molecular mechanisms that are responsible for LF development may lead to the identification of antifibrotic approaches that could help improve the treatment and prognosis of CLDs. (21) Growing evidence supports a central role of NLRP3 activation and downstream effectors, such as Casp-1 activation and IL-1β signaling in the development of LF. (7, (11) (12) (13) 22) It has been shown that level of Nlrp3 expression, among other inflammasomes, is augmented during experimental LF. (23) To date, there are only a few studies elucidating different stimuli that can trigger HSC activation and subsequent up-regulation of fibrotic markers along with activation of the NLRP3 inflammasome in both LX-2 cells, an immortalized human stellate cell line, and murine primary HSCs. (24) (25) (26) In particular, Watanabe et al. (27) not only showed that HSC expressed all of the NLRP3 inflammasome components, but also that activation of the NLRP3 inflammasome using, monosodium urate crystals, leads to a phenotypic switch from a quiescent state to collagen-producing myofibroblasts. These changes were absent in HSCs derived from apoptosis-associated speck-like protein containing CARD-deficient mice. In line with these results, our data confirm that HSC indeed possess a fully intact NLRP3 inflammasome whose activation leads to a switch toward a myofibroblast profile. This was shown by up-regulation in mRNA and protein levels for NLRP3 and IL-1β, as well as increased Casp-1 activity, along with an up-regulation of αSMA and Col1a1 after WT HSCs were exposed to LPS/ATP. This point is further demonstrated by the fact that Nlrp3 -/-HSCs failed to up-regulate fibrotic markers whereas Nlrp3 L351P/+ mutant HSC displayed a gainof-function-activated phenotype.
ROS have been demonstrated to contribute to CLD, including fibrosis, and to be one of many important NLRP3 inflammasome activators. (28) Specifically, in HSCs, an up-regulation of nicotinamide adenine dinucleotide phosphate oxidase 4 expression, a generator of ROS, was found to be associated with NLRP3 inflammasome activation and increased collagen production. (29) In connection to this, our results showed that NLRP3 inflammasome activation occurs along with increased ROS production after LPS administration and is further enhanced after subsequent treatment with ATP, representing a potential mechanism that could explain the link between NLRP3 inflammasome activation and fibrotic changes.
In the past few years, the association of the NLRP3 inflammasome to liver damage and fibrosis has been widely explored. IL-1β levels were shown to be elevated in an experimental murine fibrosis model whereas genetic depletion of IL-1ra results in an amelioration of the fibrotic phenotype. (27) Moreover, mice deficient in Casp-1, ASC, and NLRP3 have been shown to exhibit a protective effect on fibrosis development in several experimental murine models, as evidenced by decreased TGF-β and Col1a1 expression, and reduced serum levels of TIMP1 and hyaluronic acid. (13, (30) (31) (32) (33) In contrast, persistent global activation of the NLRP3 inflammasome in mice leads to severe liver inflammation, hepatocyte pyroptotic cell death, and LF. (11) However, the fact that these studies made use of global knockout mice prevents us from dissecting the cell-specific role of inflammasome pathway activation, as well as whether the profibrogenic mechanisms involved are attributed to direct effects on HSCs or indirect consequences of increased inflammation and cell death in macrophages and hepatocytes, which then influence activation of HSCs. (34) To address this issue, we used a gainof-function model with selective expression of mutant hyperactive NLRP3 in HSCs. Our results show that persistent activation of NLRP3 in HSCs resulted in a marked up-regulation of αSMA and desmin-positive cells with a perisinusoidal/pericellular distribution in liver, together with the spontaneous increase in Col secretion and development of LF. Even more interesting was that these fibrotic changes occur without the presence of inflammatory infiltrates, supporting a direct role for the NLRP3 inflammasome in HSC activation and liver fibrotic responses. These results have important translational implications for the various liver diseases, such as nonalcoholic steatohepatitis and alcoholic steatohepatitis, where the development and progression of LF represents the major cause of liver-related morbidity and mortality and suggests an antifibrotic approach by targeting NLRP3 Inflammasomes in activated myofibroblasts.
In summary, our study provides insights into the cellular mechanisms by which the NLRP3 inflammasome contributes to HSC biology and fibrogenesis and carries implications related to the development of therapeutic strategies for treatment of LF.
